The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
The FDA is beginning rulemaking to close the “adequate provision” loophole
Biocon Foundation is also expanding its reach with this first initiative in Channapatna region
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha
The safety profile in alopecia areata was generally consistent with that in approved indications, and no new safety signals were identified in this study
_256_384.jpg)
Marksans Pharma gets USFDA nod for acid reflux drug
Reinforcing commitment to ethical and sustainable growth
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
Subscribe To Our Newsletter & Stay Updated
